The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Mass Spectrometry and Protein Analysis
Domon, B., & Aebersold, R. (2006) · Science · doi:10.1126/science.1124619 · Cited by 2,181
SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM
Gold, P., & Freedman, S. O. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.122.3.467 · Cited by 1,879
Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) · Science · doi:10.1126/science.2999974 · Cited by 1,814
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Reactivity of a monoclonal antibody with human ovarian carcinoma.
Bast, R. C., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., & Knapp, R. C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110380 · Cited by 1,661
Colorectal carcinoma antigens detected by hybridoma antibodies
Koprowski, H., Steplewski, Z., Mitchell, K., Herlyn, M., Herlyn, D., & Fuhrer, P. (1979) · Somatic Cell Genetics · doi:10.1007/bf01542654 · Cited by 1,364
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., & Toyoshima, K. (1986) · Nature · doi:10.1038/319230a0 · Cited by 1,204
Etzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Radich, J., Anderson, G., & Hartwell, L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1041 · Cited by 1,155
Chromosome Studies on Normal and Leukemic Human Leukocytes
(1960) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/25.1.85 · Cited by 1,069
Prediction of cancer outcome with microarrays: a multiple random validation strategy
Michiels, S., Koscielny, S., & Hill, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17866-0 · Cited by 1,025
A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer
Chen, H.-Y., Yu, S.-L., Chen, C.-H., Chang, G.-C., Chen, C.-Y., Yuan, A., Cheng, C.-L., Wang, C.-H., Terng, H.-J., Kao, S.-F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060096 · Cited by 935
Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., & Chan, D. W. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1296 · Cited by 893
Bast, R. C., Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G., & Somerfield, M. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1865 · Cited by 879
Characterization of the Low Molecular Weight Human Serum Proteome
Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J., Conrads, T. P., & Veenstra, T. D. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300031-mcp200 · Cited by 860
Purification of a Human Prostate Specific Antigen
Wang, M. C., Valenzuela, L. A., Murphy, G. P., & Chu, T. M. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.100 · Cited by 825
Lymphangiogenesis and cancer metastasis
Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E., & Alitalo, K. (2002) · Nature Reviews Cancer · doi:10.1038/nrc863 · Cited by 797
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748
Differential exoprotease activities confer tumor-specific serum peptidome patterns
Villanueva, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26022 · Cited by 741
Serum Proteomic Patterns for Detection of Prostate Cancer
Petricoin, E. F. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1576 · Cited by 736
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Hellström, I., Raycraft, J., Hayden-Ledbetter, M. S., Ledbetter, J. A., Schummer, M., McIntosh, M. W., Drescher, C. W., Urban, N. D., & Hellström, K. E. (2003) · PubMed · Cited by 711
Welsh, J. B., Zarrinkar, P. P., Sapinoso, L. M., Kern, S. G., Behling, C. A., Monk, B. J., Lockhart, D. J., Burger, R. A., & Hampton, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1176 · Cited by 654
The emerging roles of human tissue kallikreins in cancer
Borgoño, C. A., & Diamandis, E. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1474 · Cited by 650
Self-citationProteomic patterns of tumour subsets in non-small-cell lung cancer
Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P., Larsen, P. H., White, B. C., Roberts, J. R., Edgerton, M., Gonzalez, A., Nadaf, S., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14068-8 · Cited by 602
PRODUCTION OF EMBRYONAL α-GLOBULIN BY TRANSPLANTABLE MOUSE HEPATOMAS
Abelev, G. I., Perova, S. D., KHRAMKOVA, N. I., POSTNIKOVA, Z. A., & Irlin, I. S. (1963) · Transplantation · doi:10.1097/00007890-196301020-00004 · Cited by 595
Autoantibody Signatures in Prostate Cancer
Wang, X., Yu, J., Sreekumar, A., Varambally, S., Shen, R., Giacherio, D., Mehra, R., Montie, J. E., Pienta, K. J., Sanda, M. G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051931 · Cited by 582
KUFE, D., INGHIRAMI, G., ABE, M., HAYES, D., JUSTI-WHEELER, H., & SCHLOM, J. (1984) · Hybridoma · doi:10.1089/hyb.1984.3.223 · Cited by 573
Clinical proteomics: Written in blood
Liotta, L. A., Ferrari, M., & Petricoin, E. (2003) · Nature · doi:10.1038/425905a · Cited by 534
Hilkens, J., Buijs, F., Hilgers, J., Hageman, P., Calafat, J., Sonnenberg, A., & Van Vlak, M. D. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340210 · Cited by 488
Microarray Analysis and Tumor Classification
Quackenbush, J. (2006) · New England Journal of Medicine · doi:10.1056/nejmra042342 · Cited by 455
Comprehensive analysis of HE4 expression in normal and malignant human tissues
Galgano, M. T., Hampton, G. M., & Frierson, H. F. (2006) · Modern Pathology · doi:10.1038/modpathol.3800612 · Cited by 437
Current status of estrogen and progesterone receptors in breast cancer
McGuire, W. L., Horwitz, K. B., Pearson, O. H., & Segaloff, A. (1977) · Cancer · doi:10.1002/1097-0142(197706)39:6<2934::aid-cncr2820390680>3.0.co;2-p · Cited by 388
Weigelt, B., Hu, Z., He, X., Livasy, C., Carey, L. A., Ewend, M. G., Glas, A. M., Perou, C. M., & van't Veer, L. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2553 · Cited by 332
A prostate antigen in sera of prostatic cancer patients.
Papsidero, L. D., Wang, M. C., Valenzuela, L., Murphy, G. P., & Chu, T. M. (1980) · PubMed · Cited by 329
Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?
Diamandis, E. P. (2003) · Clinical Chemistry · doi:10.1373/49.8.1272 · Cited by 324
Self-citationIdentification by cDNA microarray of genes involved in ovarian carcinogenesis.
Ono, K., Tanaka, T., Tsunoda, T., Kitahara, O., Kihara, C., Okamoto, A., Ochiai, K., Takagi, T., & Nakamura, Y. (2000) · PubMed · Cited by 307
Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment
Celis, J. E., Gromov, P., Cabezón, T., Moreira, J. M. A., Ambartsumian, N., Sandelin, K., Rank, F., & Gromova, I. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400009-mcp200 · Cited by 305
Rittenhouse, H. G., Finlay, J. A., Mikolajczyk, S. D., & Partin, A. W. (1998) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408369891234219 · Cited by 303
Early Diagnosis of Medullary Carcinoma of the Thyroid Gland by Means of Calcitonin Assay
Melvin, K. E. W., Miller, H. H., & Tashjian, A. H. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111112852004 · Cited by 297
Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer
Baggerly, K. A., Morris, J. S., Edmonson, S. R., & Coombes, K. R. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji008 · Cited by 294
Rosty, C., Christa, L., Kuzdzal, S. A., Baldwin, W. M., ZAHURAK, M. L., Carnot, F., Chan, D. W., Canto, M. I., Lillemoe, K. D., Cameron, J. L., et al. (2002) · PubMed · Cited by 292
Microarrays and molecular research: noise discovery?
Ioannidis, J. P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17878-7 · Cited by 287
Towards a novel classification of human malignancies based on gene expression patterns
Alizadeh, A. A., Ross, D. T., Perou, C. M., & van de Rijn, M. (2001) · The Journal of Pathology · doi:10.1002/path.889 · Cited by 280
Lessons from Controversy: Ovarian Cancer Screening and Serum Proteomics
Ransohoff, D. F. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji054 · Cited by 264
Banks, R. E., Stanley, A. J., Cairns, D. A., Barrett, J. H., Clarke, P., Thompson, D., & Selby, P. J. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.051417 · Cited by 240
Diamandis, E. P., Scorilas, A., Fracchioli, S., van Gramberen, M., de Bruijn, H., Henrik, A., Soosaipillai, A., Grass, L., Yousef, G. M., Stenman, U.-H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.022 · Cited by 234
Self-citationKoomen, J. M., Li, D., Xiao, L.-C., Liu, T. C., Coombes, K. R., Abbruzzese, J., & Kobayashi, R. (2005) · Journal of Proteome Research · doi:10.1021/pr050046x · Cited by 223
Paradis, V., Degos, F., Dargère, D., Pham, N., Belghiti, J., Degott, C., Janeau, J.-L., Bezeaud, A., Delforge, D., Cubizolles, M., et al. (2005) · Hepatology · doi:10.1002/hep.20505 · Cited by 220
III. On a new substance occurring in the urine of a patient with mollities ossium
Jones, H. B. (1848) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1848.0003 · Cited by 218
Practice Guidelines for Tumor Marker Use in the Clinic
Sturgeon, C. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1151 · Cited by 202
Tolson, J., Bogumil, R., Brunst, E., Beck, H., Elsner, R., Humeny, A., Kratzin, H., Deeg, M., Kuczyk, M., Mueller, G. A., et al. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700097 · Cited by 198
Whiteaker, J. R., Zhang, H., Zhao, L., Wang, P., Kelly-Spratt, K. S., Ivey, R. G., Piening, B. D., Feng, L.-C., Kasarda, E., Gurley, K. E., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070202v · Cited by 179
American association for clinical chemistry
(1981) · Gene · doi:10.1016/0378-1119(81)90119-0 · Cited by 178
Tumor markers. Physiology, pathobiology, technology, and clinical applications
Wu, A. H. B. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00049-4 · Cited by 172
Head-to-Head Comparison of Serum Fractionation Techniques
Whiteaker, J. R., Zhang, H., Eng, J. K., Fang, R., Piening, B. D., Feng, L.-C., Lorentzen, T. D., Schoenherr, R. M., Keane, J. F., Holzman, T., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr0604920 · Cited by 165
Contribution of Protein Fractionation to Depth of Analysis of the Serum and Plasma Proteomes
Faca, V., Pitteri, S. J., Newcomb, L., Glukhova, V., Phanstiel, D., Krasnoselsky, A., Zhang, Q., Struthers, J., Wang, H., Eng, J., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070233q · Cited by 164
Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network
Finne, P., Finne, R., Auvinen, A. P., Juusela, H., Aro, J. L. V., Määttänen, L., Hakama, M., Rannikko, S., Tammela, T. L. J., & Stenman, U. (2000) · Urology · doi:10.1016/s0090-4295(00)00672-5 · Cited by 152
Peptidomics for Cancer Diagnosis: Present and Future
Diamandis, E. P. (2006) · Journal of Proteome Research · doi:10.1021/pr060225u · Cited by 143
Self-citationStephan, C., Cammann, H., Semjonow, A., Diamandis, E. P., Wymenga, L. F. A., Lein, M., Sinha, P. K., Loening, S. A., & Jung, K. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1279 · Cited by 139
Self-citationChen, Y., Zheng, S. S., Yu, J., & Hu, X. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1162-03 · Cited by 137
Lopez, M. F., Mikulskis, A., Kuzdzal, S. A., Bennett, D. A., Kelly, J., Golenko, E. E., DiCesare, J. L., Denoyer, E. R., Patton, W. F., Ediger, R., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.053090 · Cited by 137
Proteomic Approaches to the Diagnosis, Treatment, and Monitoring of Cancer
Wulfkuhle, J. D., Paweletz, C. P., Steeg, P. S., Petricoin, E. F., & Liotta, L. A. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_7 · Cited by 126
Tumor Markers : Physiology, Pathobiology, Technology, and Clinical Applications
Fritsche, H. A., Diamandis, E. P., & Lilja, H. G. (2002) · Cited by 126
Self-citationCellular aspects of alpha-fetoprotein reexpression in tumors
Abelev, G. I., & Eraiser, T. L. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0084 · Cited by 116
Analytical and Preanalytical Biases in Serum Proteomic Pattern Analysis for Breast Cancer Diagnosis
Karsan, A., Eigl, B. J., Flibotte, S., Gelmon, K. A., Switzer, P., Hassell, P., Harrison, D., Law, J. H., Hayes, M. M., Stillwell, M., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050708 · Cited by 116
Lopez, M. F., Mikulskis, A., Kuzdzal, S. A., Golenko, E. E., Petricoin, E. F., Liotta, L. A., Patton, W. F., Whiteley, G., Rosenblatt, K. P., Gurnani, P., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.080721 · Cited by 113
The role of the microenvironment and intercellular cross-talk in tumor angiogenesis
Ahmad, S. A., Jung, Y. D., Liu, W., Reinmuth, N., Parikh, A. A., Stoeltzing, O., Fan, F., & Ellis, L. M. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0418 · Cited by 111
Harper, R. G., Workman, S. R., Schuetzner, S., Timperman, A. T., & Sutton, J. N. (2004) · Electrophoresis · doi:10.1002/elps.200405864 · Cited by 107
Identification of Patients With Head and Neck Cancer Using Serum Protein Profiles
Wadsworth, J. T., Somers, K. D., Stack, B. C., Cazares, L. H., Malik, G., Adam, B.-L., Wright, G. L., & Semmes, O. J. (2004) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.130.1.98 · Cited by 107
A Perspective on DNA Microarrays in Pathology Research and Practice
Pollack, J. R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070342 · Cited by 58
Biological implications of SNPs in signal peptide domains of human proteins
Jarjanazi, H., Savas, S., Pabalan, N., Dennis, J. W., & Özçelik, H. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21548 · Cited by 54
Searching for pathogenic epitopes in thyroglobulin: parameters and caveats
Carayanniotis, G., & Rao, V. P. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10073-6 · Cited by 45
Discovery of cancer biomarkers through the use of mouse models
Kuick, R. D., Misek, D. E., Monsma, D. J., Webb, C. P., Wang, H., Peterson, K. J., Pisano, M. R., Omenn, G. S., & Hanash, S. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.032 · Cited by 32
Rai, D. K., Green, B. N., Landin, B., Alvélius, G., & Griffiths, W. J. (2004) · Journal of Mass Spectrometry · doi:10.1002/jms.581 · Cited by 15
Cited by
Liquid Biopsy: From Discovery to Clinical Application
Alix-Panabières, C., & Pantel, K. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1311 · Cited by 953
Electrochemical Immunosensors for Detection of Cancer Protein Biomarkers
Chikkaveeraiah, B. V., Bhirde, A. A., Morgan, N. Y., Eden, H. S., & Chen, X. (2012) · ACS Nano · doi:10.1021/nn3023969 · Cited by 719
Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer
Rusling, J. F., Kumar, C. V., Gutkind, J. S., & Patel, V. (2010) · The Analyst · doi:10.1039/c0an00204f · Cited by 552
MicroRNAs: Novel Biomarkers for Human Cancer
Bartels, C. L., & Tsongalis, G. J. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112805 · Cited by 529
Unravelling the complexity of metastasis — molecular understanding and targeted therapies
Sethi, N., & Kang, Y. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3125 · Cited by 397
Metadata
- Authors
- Kulasingam, V., & Diamandis, E. P.
- Venue
- Nature Clinical Practice Oncology
- Published
- 2008-08-12
- Volume
- 5
- Issue
- 10
- Pages
- 588-599
- ISSN
- 1743-4254 (ISSN-L)
- 1743-4262
- OpenAlex
- W2017777108
- Cited by
- 771
- References
- 89
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.